4/A

FORM 4/A SUBMISSION

Company: Akebia Therapeutics, Inc.
Filed: July 2, 2015
Period of Report: January 1, 2015
Accession Number: 0001209191-15-058357

View Document ↗ View on SEC.gov ↗